Rupee falls 4 paise to recent low of 88.79 towards U.S. greenback

The rupee fell 4 paise to an all-time low of 88.79 (provisional) towards the U.S. greenback on Tuesday (September 30, 2025), pressured by sustained overseas capital outflows amid international commerce uncertainties.

However, a steep fall in international crude oil costs, together with a weaker buck, prevented a pointy decline within the native unit, in keeping with foreign exchange merchants.

The markets are additionally awaiting the Reserve Bank of India’s (RBI’s) Monetary Policy Committee determination, which can be introduced on Wednesday (October 1).

At the interbank overseas trade, the rupee opened at 88.73 towards the greenback and traded within the vary of 88.69-88.80 earlier than settling at 88.79 (provisional), decrease by 4 paise towards its earlier shut.

The rupee consolidated in a slim vary and settled decrease by 3 paise at 88.75 towards the buck on Monday.

“Constant pressure from FPIs buying dollars brought down the rupee, where the RBI seems to be present, supplying dollars. The rupee has remained vulnerable to the FPIs selling due to the trade trauma seen since August, when U.S. President Donald Trump applied 50% tariffs on Indian Exports,” Anil Kumar Bhansali, Head of Treasury and Executive Director, Finrex Treasury Advisors LLP, mentioned.

The vary for Wednesday (October 1) is anticipated between 88.50 and 89.00, he mentioned.

The RBI assembly is going down towards the backdrop of ongoing geopolitical tensions and the U.S. imposing 50% tariffs on Indian shipments.

Meanwhile, the greenback index, which gauges the buck’s power towards a basket of six currencies, was buying and selling at 97.79, decrease by 0.11%.

Brent crude, the worldwide oil benchmark, was buying and selling 1.03% decrease at $67.27 per barrel in futures commerce.

On the home fairness market entrance, Sensex dropped 97.32 factors to settle at 80,267.62, whereas Nifty slipped 23.80 factors to 24,611.10.

Foreign Institutional Investors offloaded equities price ₹2,831.59 crore on Monday, in keeping with trade knowledge.

Meanwhile, the U.S. has introduced the imposition of a 100% tariff on branded or patented medicine getting into the U.S. from October 1, apart from pharmaceutical corporations constructing manufacturing vegetation within the U.S.